However, in a study investigating PS19 mice with TREM2 KO, researchers found a reduction in brain atrophy in the absence of any changes in tauopathy or a reduction of MGnD-associated markers APOE and Cst7 (Krasemann et al., 2017; Leyns et al., 2017). Here, TREM2 is linked to tauopathy.